{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:26:22Z","timestamp":1762017982293},"reference-count":23,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b16-00781","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T22:21:55Z","timestamp":1485901315000},"page":"205-211","source":"Crossref","is-referenced-by-count":14,"title":["Preparation and Evaluation of PEGylated Poly-L-ornithine Complex as a Novel Absorption Enhancer"],"prefix":"10.1248","volume":"40","author":[{"given":"Yusuke","family":"Kamiya","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Yamaki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Hatanaka","sequence":"additional","affiliation":[{"name":"Tokai University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Ogihara","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideshi","family":"Natsume","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hosoya K, Kubo H, Natsume H, Sugibayashi K, Morimoto Y. Evaluation of enhancers to increase nasal absorption using Ussing chamber technique. <i>Biol. Pharm. Bull.<\/i>, <b>17<\/b>, 316\u2013322 (1994).","DOI":"10.1248\/bpb.17.316"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hosoya K, Kubo H, Natsume H, Sugibayashi K, Morimoto Y, Yamashita S. The structural barrier of absorptive mucosae: site difference of the permeability of fluorescein isothiocyanate-labelled dextran in rabbits. <i>Biopharm. Drug Dispos.<\/i>, <b>14<\/b>, 685\u2013695 (1993).","DOI":"10.1002\/bdd.2510140805"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) McMartin C, Hutchinson LE, Hyde R, Peters GE. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. <i>J. Pharm. Sci.<\/i>, <b>76<\/b>, 535\u2013540 (1987).","DOI":"10.1002\/jps.2600760709"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Natsume H, Iwata S, Ohtake K, Miyamoto M, Yamaguchi M, Hosoya K, Kobayashi D, Sugibayashi K, Morimoto Y. Screening of cationic compounds as an absorption enhancer for nasal drug delivery. <i>Int. J. Pharm.<\/i>, <b>185<\/b>, 1\u201312 (1999).","DOI":"10.1016\/S0378-5173(99)00100-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ohtake K, Maeno T, Ueda H, Natsume H, Morimoto Y. Poly-L-arginine predominantly increases the paracellular permeability of hydrophilic macromolecules across rabbit nasal epithelium <i>in vitro.<\/i> <i>Pharm. Res.<\/i>, <b>20<\/b>, 153\u2013160 (2003).","DOI":"10.1023\/A:1022485816755"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yamaki T, Ohtake K, Ichikawa K, Uchida M, Uchida H, Ohshima S, Juni K, Kobayashi J, Morimoto Y, Natsume H. Poly-L-arginine-induced internalization of tight junction proteins increases the paracellular permeability of the Caco-2 cell monolayer to hydrophilic macromolecules. <i>Biol. Pharm. Bull.<\/i>, <b>36<\/b>, 432\u2013441 (2013).","DOI":"10.1248\/bpb.b12-00878"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ohtake K, Natsume H, Ueda H, Morimoto Y. Analysis of transient and reversible effects of poly-L-arginine on the <i>in vivo<\/i> nasal absorption of FITC-dextran in rats. <i>J. Control. Release<\/i>, <b>82<\/b>, 263\u2013275 (2002).","DOI":"10.1016\/S0168-3659(02)00128-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Miyamoto M, Natsume H, Satoh I, Ohtake K, Yamaguchi M, Kobayashi D, Sugibayashi K, Morimoto Y. Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats. <i>Int. J. Pharm.<\/i>, <b>226<\/b>, 127\u2013138 (2001).","DOI":"10.1016\/S0378-5173(01)00797-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ohtake K, Maeno T, Ueda H, Ogihara M, Natsume H, Morimoto Y. Poly-L-arginine enhances paracellular permeability <i>via<\/i> serine\/threonine phosphorylation of ZO-1 and tyrosine dephosphorylation of occludin in rabbit nasal epithelium. <i>Pharm. Res.<\/i>, <b>20<\/b>, 1838\u20131845 (2003).","DOI":"10.1023\/B:PHAM.0000003383.86238.d1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Soane RJ, Frier M, Perkins AC, Jones NS, Davis SS, Illum L. Evaluation of the clearance characteristics of bioadhesive systems in humans. <i>Int. J. Pharm.<\/i>, <b>178<\/b>, 55\u201365 (1999).","DOI":"10.1016\/S0378-5173(98)00367-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Gizurarson S. The effect of cilia and the mucociliary clearance on successful drug delivery. <i>Biol. Pharm. Bull.<\/i>, <b>38<\/b>, 497\u2013506 (2015).","DOI":"10.1248\/bpb.b14-00398"},{"key":"12","unstructured":"12) Irie H, Ohtake K, Maeno T, Uchida M, Uchida H, Kobayashi J, Natsume H. Relationship between calcein disposition in nasal cavity and blood concentration after intranasal administration of viscous calcein-loaded starch solution in rats. <i>J. Pharm. Sci. Technol. Jpn.<\/i>, <b>69<\/b>, 219\u2013227 (2009)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ananda K, Manjula BN, Meng F, Acharya VN, Intaglietta M, Acharya SA. Packing density of the PEG-shell in PEG-albumins: PEGylation induced viscosity and COP are inverse correlate of packing density. <i>Artif. Cells Blood Substit. Immobil. Biotechnol.<\/i>, <b>40<\/b>, 14\u201327 (2012).","DOI":"10.3109\/10731199.2011.579568"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O\u2019Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ. Peginterferon alfa-2a in patients with chronic hepatitis C. <i>N. Engl. J. Med.<\/i>, <b>343<\/b>, 1666\u20131672 (2000).","DOI":"10.1056\/NEJM200012073432301"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Lee KC, Tak KK, Park MO, Lee JT, Woo BH, Yoo SD, Lee HS, DeLuca PP. Preparation and characterization of polyethylene\u2013glycol-modified salmon calcitonins. <i>Pharm. Dev. Technol.<\/i>, <b>4<\/b>, 269\u2013275 (1999).","DOI":"10.1081\/PDT-100101361"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kim TH, Jiang HH, Lim SM, Youn YS, Choi KY, Lee S, Chen X, Byun Y, Lee LC. Site-specific PEGylated Exendin-4 modified with a high molecular weight trimeric PEG reduces steric hindrance and increases type 2 antidiabetic therapeutic effects. <i>Bioconjug. Chem.<\/i>, <b>23<\/b>, 2214\u20132220 (2012).","DOI":"10.1021\/bc300265n"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Veronese FM, Mero A. The impact of PEGylation on biological therapies. <i>BioDrugs<\/i>, <b>22<\/b>, 315\u2013329 (2008).","DOI":"10.2165\/00063030-200822050-00004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Huang Y, Leobandung W, Foss A, Peppas NA. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. <i>J. Control. Release<\/i>, <b>65<\/b>, 63\u201371 (2000).","DOI":"10.1016\/S0168-3659(99)00233-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gol RM, Jewrajka SK. Facile <i>in situ<\/i> PEGylation of polyamide thin film composite membranes for improving fouling resistance. <i>J. Membr. Sci.<\/i>, <b>455<\/b>, 271\u2013282 (2014).","DOI":"10.1016\/j.memsci.2013.12.058"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Brown MD, Sch\u00e4tzlein A, Brownlie A, Jack V, Wang W, Tetley L, Gray AI, Uchegbu IF. Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. <i>Bioconjug. Chem.<\/i>, <b>11<\/b>, 880\u2013891 (2000).","DOI":"10.1021\/bc000052d"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Castile J, Cheng YH, Simmons B, Perelman M, Smith A, Watts P. Development of <i>in vitro<\/i> models to demonstrate the ability of PecSys<sup>\u00ae<\/sup>, an <i>in situ<\/i> nasal gelling technology, to reduce nasal run-off and drip. <i>Drug Dev. Ind. Pharm.<\/i>, <b>39<\/b>, 816\u2013824 (2013).","DOI":"10.3109\/03639045.2012.707210"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Yamaki T, Kamiya Y, Ohtake K, Uchida M, Seki T, Ueda H, Kobayashi J, Morimoto Y, Natsume H. A mechanism enhancing macromolecule transport through paracellular spaces induced by Poly-L-arginine: Poly-L-arginine induces the internalization of tight junction proteins <i>via<\/i> clathrin-mediated endocytosis. <i>Pharm. Res.<\/i>, <b>31<\/b>, 2287\u20132296 (2014).","DOI":"10.1007\/s11095-014-1324-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Maher S, McClean S. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells <i>in vitro.<\/i> <i>Biochem. Pharmacol.<\/i>, <b>71<\/b>, 1289\u20131298 (2006).","DOI":"10.1016\/j.bcp.2006.01.012"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/2\/40_b16-00781\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T09:27:56Z","timestamp":1498382876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/2\/40_b16-00781\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00781","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}